North American biologics market is estimated to grow at a CAGR of 8.4% during the forecast period. Some pivotal factors encouraging the market growth include the rising cancer incidences and increasing demand for monoclonal antibody therapeutics. As per the estimation by the American Cancer Society (ACS), over 1.8 million new cancer incidences are expected to be diagnosed in 2020. The increasing survival rate shows significant awareness regarding cancer diagnosis and treatment in the country. This, in turn, is leading to an increasing demand for biologics drugs which acts as an immune system substance that supports to augment the body’s ability to fight against cancer. Types of biological drugs comprise vaccines, allergens, blood, tissues, recombinant proteins, blood components, cells, and genes. Biologic drugs are utilized to treat multiple conditions and are the most available advanced therapies. Apart from cancer, biologic drugs are utilized for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, and other autoimmune diseases.

Visit for Global Biologics Market Report at: https://www.omrglobal.com/industry-reports/biologics-market

North American biologics market is segmented based on product and application. Based on the product, the market is segmented into antibody therapeutics, vaccines, cell therapy, gene therapy, and others. Rising US FDA launches of monoclonal antibody drugs coupled with the increasing prevalence of cancer and autoimmune diseases are supporting to drive the market growth. Monoclonal antibodies are regarded as one of the potential therapeutics for both solid tumors and hematologic malignancies. This type of immunotherapy stimulates the immune system of cancer patients and supports to discover and attack cancerous cells. Based on application, the market is segmented into cancer, autoimmune diseases, infectious diseases, and others.

Some key players in the market include AbbVie Inc., Amgen Inc., Pfizer Inc., F. Hoffman-La Roche AG, and Boehringer Ingelheim GmbH. The companies are focusing on new product launches and mergers and acquisitions, to gain a significant market share. For instance, in September 2019, H. Lundbeck A/S declared a definitive agreement for Lundbeck to acquire Alder, a clinical-stage biopharmaceutical company that is committed to transforming migraine treatment ranging from the discovery, development, and commercialization of novel therapeutic antibodies. With this acquisition, Lundbeck will constantly widen the range of brain disorders. By acquiring Alder, Lundbeck will further increase its capabilities to offer future biological innovations in brain diseases.

Research Methodology

The market study of the North American biologics market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings the authenticity in our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.
• Whitepapers, research-papers, and news blogs.
• Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

1. North American biologics Market Research and Analysis by Product
2. North American biologics Market Research and Analysis by Application

The Report Covers

• Comprehensive research methodology of the North American biologics market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the North American biologics market.
• Insights about market determinants which are stimulating the North American biologics market.
• Detailed and extensive market segments with regional distribution of forecasted revenues.
• Extensive profiles and recent developments of market players.